Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Pulmonary Hypertension | Research

The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea

Authors: Lu Yan, Zhihui Zhao, Qing Zhao, Qi Jin, Yi Zhang, Xin Li, Anqi Duan, Qin Luo, Zhihong Liu

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Objective

Obstructive sleep apnoea (OSA) is one cause of pulmonary hypertension (PH) and can also emerge along with PH. The clinical diagnosis and treatment of OSA in patients with PH are still controversial. The purpose of this clinical observation study was to observe and summarize the incidence and clinical characteristics of OSA in patients with PH and to explore possible predictors of PH combined with OSA.

Methods

Patients with PH diagnosed by right heart catheterization who underwent overnight cardiorespiratory monitoring from December 2018 to December 2020 were enrolled. OSA was defined as an apnoea–hypopnoea index of ≥ 5/h with ≥ 50% of apnoeic events being obstructive. Baseline clinical characteristics and parameters were collected to compare PH patients with and without OSA. Logistic regression analysis was run to determine the risk factors for OSA in PH patients.

Results

A total of 35 (25%) of 140 patients had OSA. OSA is relatively frequent in patients with PH, especially in patients with chronic thromboembolic pulmonary hypertension and patients with lung disease– or hypoxia-associated PH. The patients who had OSA were mostly male and had a higher age and a lower daytime arterial oxygen pressure. Logistic regression analysis found that older age, male sex, and lower daytime arterial blood oxygen pressure correlated with OSA in PH patients.

Conclusion

OSA is common in patients with PH. Lower daytime arterial oxygen pressure is a risk factor for OSA in older male patients with PH.
Literature
1.
go back to reference Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.CrossRef Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.CrossRef
2.
go back to reference Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34(4):888–94.CrossRef Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34(4):888–94.CrossRef
3.
go back to reference Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42–50.CrossRef Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42–50.CrossRef
4.
go back to reference Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. CrossRef Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. CrossRef
5.
go back to reference Pulmonary Embolism and Pulmonary Vascular Disease Group of Respiratory Medicine Branch of Chinese Medical Association, Pulmonary Embolism and Pulmonary Vascular Disease Working Committee of Respiratory Physician Branch of Chinese Medical Doctor Association, National Cooperative Group for Prevention and Treatment of Pulmonary Embolism and Pulmonary Vascular Disease, etc. Diagnosis of Pulmonary Hypertension in China And treatment guidelines (2021 edition). Chinese Med J. 2021;101(1):11–51. Pulmonary Embolism and Pulmonary Vascular Disease Group of Respiratory Medicine Branch of Chinese Medical Association, Pulmonary Embolism and Pulmonary Vascular Disease Working Committee of Respiratory Physician Branch of Chinese Medical Doctor Association, National Cooperative Group for Prevention and Treatment of Pulmonary Embolism and Pulmonary Vascular Disease, etc. Diagnosis of Pulmonary Hypertension in China And treatment guidelines (2021 edition). Chinese Med J. 2021;101(1):11–51.
6.
go back to reference Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164–72.CrossRef Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164–72.CrossRef
7.
go back to reference Young T, Peppard PE, Gottlieb DJ, et al. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217–39.CrossRef Young T, Peppard PE, Gottlieb DJ, et al. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217–39.CrossRef
8.
go back to reference Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee. Circulation. 2008;118(10):1080–111.CrossRef Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee. Circulation. 2008;118(10):1080–111.CrossRef
9.
go back to reference Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep Apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69(7):841–58.CrossRef Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep Apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69(7):841–58.CrossRef
10.
go back to reference Dumitrascu R, Tiede H, Eckermann J, et al. Sleep apnea in precapillary pulmonary hypertension. Sleep Med. 2013;14:247–51.CrossRef Dumitrascu R, Tiede H, Eckermann J, et al. Sleep apnea in precapillary pulmonary hypertension. Sleep Med. 2013;14:247–51.CrossRef
11.
go back to reference Sajkov D, Wang T, Saunders NA, et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518–26.CrossRef Sajkov D, Wang T, Saunders NA, et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518–26.CrossRef
12.
go back to reference Wong HS, Williams AJ, Mok Y, et al. The relationship between pulmonary hypertension and obstructive sleep apnea. Curr Opin Pulm Med. 2017;23(6):517–21.CrossRef Wong HS, Williams AJ, Mok Y, et al. The relationship between pulmonary hypertension and obstructive sleep apnea. Curr Opin Pulm Med. 2017;23(6):517–21.CrossRef
13.
go back to reference Nokes B, Raza H, Malhotra A, et al. Pulmonary hypertension and obstructive sleep apnea. J Clin Sleep Med. 2020;16(4):649.CrossRef Nokes B, Raza H, Malhotra A, et al. Pulmonary hypertension and obstructive sleep apnea. J Clin Sleep Med. 2020;16(4):649.CrossRef
14.
go back to reference ERJ September Podcast: Challenges and perspectives in obstructive sleep apnoea. Eur Respir J. 2018;52(3):18E5203. ERJ September Podcast: Challenges and perspectives in obstructive sleep apnoea. Eur Respir J. 2018;52(3):18E5203.
15.
go back to reference Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009;51(5):363–70.CrossRef Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009;51(5):363–70.CrossRef
16.
go back to reference Grimm W, Hildebrandt O, Nell C, et al. Excessive daytime sleepiness and central sleep apnea in patients with stable heart failure. Int J Cardiol. 2014;176:1447–8.CrossRef Grimm W, Hildebrandt O, Nell C, et al. Excessive daytime sleepiness and central sleep apnea in patients with stable heart failure. Int J Cardiol. 2014;176:1447–8.CrossRef
17.
go back to reference Ulrich S, Fischler M, Speich R, et al. Sleep-related breathing disorders in patients with pulmonary hypertension. Chest. 2008;133:1375–80.CrossRef Ulrich S, Fischler M, Speich R, et al. Sleep-related breathing disorders in patients with pulmonary hypertension. Chest. 2008;133:1375–80.CrossRef
18.
go back to reference Oa M, Cm P, Ja G, et al. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest. 2007;131:109–17.CrossRef Oa M, Cm P, Ja G, et al. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest. 2007;131:109–17.CrossRef
19.
go back to reference Hildenbrand FF, Bloch KE, Speich R, et al. Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Respiration. 2012;84:477–84.CrossRef Hildenbrand FF, Bloch KE, Speich R, et al. Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Respiration. 2012;84:477–84.CrossRef
20.
go back to reference Jilwan FN, Escourrou P, Garcia G, et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013;143:47–55.CrossRef Jilwan FN, Escourrou P, Garcia G, et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013;143:47–55.CrossRef
21.
go back to reference Epstein MD, Segal LN, Ibrahim SM, et al. Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep. 2010;33:1069–74.CrossRef Epstein MD, Segal LN, Ibrahim SM, et al. Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep. 2010;33:1069–74.CrossRef
22.
go back to reference Arzt M, Luigart R, Schum C, et al. Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism. Eur Respir J. 2012;40:919–24.CrossRef Arzt M, Luigart R, Schum C, et al. Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism. Eur Respir J. 2012;40:919–24.CrossRef
23.
go back to reference Stenmark KR, Fagan KA, Frid MG, et al. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675–91.CrossRef Stenmark KR, Fagan KA, Frid MG, et al. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675–91.CrossRef
24.
go back to reference Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165(2):152–8.CrossRef Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165(2):152–8.CrossRef
25.
go back to reference Simonson J, Greenberg H, Talwar A. Pulmonary artery dilation and obstructive sleep apnea. J Clin Sleep Med. 2020;16(4):647.CrossRef Simonson J, Greenberg H, Talwar A. Pulmonary artery dilation and obstructive sleep apnea. J Clin Sleep Med. 2020;16(4):647.CrossRef
26.
go back to reference Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367(10):913–21.CrossRef Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367(10):913–21.CrossRef
27.
go back to reference Nokes BT, Raza HA, Cartin-Ceba R, et al. Individuals with scleroderma may have increased risk of sleep-disordered breathing. J Clin Sleep Med. 2019;15(11):1665–9.CrossRef Nokes BT, Raza HA, Cartin-Ceba R, et al. Individuals with scleroderma may have increased risk of sleep-disordered breathing. J Clin Sleep Med. 2019;15(11):1665–9.CrossRef
28.
go back to reference Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA. 2017;317(21):2177–86.CrossRef Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA. 2017;317(21):2177–86.CrossRef
Metadata
Title
The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea
Authors
Lu Yan
Zhihui Zhao
Qing Zhao
Qi Jin
Yi Zhang
Xin Li
Anqi Duan
Qin Luo
Zhihong Liu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01755-5

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.